DexCom DXCM
First Signal's file · in 1 issue · All companies
Continuous glucose monitors
Every time it made the issue
We cover a company only when it moves enough to matter. Each row is one of those days, what we made of it, and how the stock did over the next 5 and 20 trading days, next to the S&P 500.
| Date | Where | Move | Our read | 5 days later | 20 days later |
|---|---|---|---|---|---|
| Fri, Nov 6, 2026 | Earnings | −6.0% | Fell with insulin-pump maker Insulet, whose call lowered its preliminary 2027 growth framework; Insulet's release raised its 2026 outlook. | to come | to come |
Its biggest days of the past ten years
| Best days | Move |
|---|---|
| Thu, Aug 2, 2018 | +30.6% |
| Thu, Nov 7, 2019 | +27.2% |
| Fri, Jan 13, 2017 | +25.9% |
| Worst days | Move |
|---|---|
| Fri, Jul 26, 2024 | −40.7% |
| Thu, Sep 28, 2017 | −32.7% |
| Wed, Nov 2, 2016 | −19.2% |
How it took its last 8 reports
The stock's move in the first session after each quarterly report. Next report: Thursday, February 11, 2027.
| Results filed | Next session |
|---|---|
| Thu, Oct 29, 2026 | +3.0% |
| Thu, Jul 30, 2026 | +12.0% |
| Thu, Apr 30, 2026 | +3.0% |
| Thu, Feb 12, 2026 | +7.6% |
| Thu, Oct 30, 2025 | −14.6% |
| Wed, Jul 30, 2025 | −9.3% |
| Thu, May 1, 2025 | +16.2% |
| Thu, Feb 13, 2025 | +5.9% |
Moves are daily closing prices. Past moves don't predict future ones.
